SCHEMBL7051178

SCHEMBL7051178

C[C](C=O)NCC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6535964 0.73
SCHEMBL91326 0.70
Hydrochloric Acid SCHEMBL30777456 0.69
Sulfuric Acid SCHEMBL6255662 0.67 CYP2D6 (0.45)
SCHEMBL1275889 0.67 CYP2D6 (0.65)
Acetone SCHEMBL2672218 0.67 CYP2D6 (0.50)
SCHEMBL6850946 0.67 CYP2D6 (0.65)
SCHEMBL2952595 0.67 CYP2D6 (0.50)
SCHEMBL2952594 0.67 CYP2D6 (0.50)
SCHEMBL7161352 0.67 CNR2 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299349-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-04-09 EP disclosed
WO-2002002505-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO disclosed